Herbals making therapeutic claims should be Rx or OTC drugs, CSPI tells commission.
This article was originally published in The Tan Sheet
Executive Summary
HERBALS MAKING THERAPEUTIC CLAIMS SHOULD BE Rx OR OTC DRUGS, CSPI suggests in Aug. 4 comments responding to the President's Commission on Dietary Supplement Labels draft report on dietary supplement labeling, claims and safety. "We urge the commission to recommend that the FDA categorize herbal products making therapeutic claims as either prescription or over-the-counter drugs, depending upon whether such products can be used safely without medical supervision," the Center for Science in the Public Interest says. The draft report was issued June 4 ("The Tan Sheet" June 30, pp. 17-25). CSPI is a non-profit consumer group with 1 mil. members.